Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-25-000095
Filing Date
2025-01-08
Accepted
2025-01-08 17:25:15
Documents
1
Period of Report
2025-01-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312227001_01082025.html 3  
1 OWNERSHIP DOCUMENT form312227001_01082025.xml 3 2274
  Complete submission text file 0000921895-25-000095.txt   3857
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44 ZAYT SHEMEN ST. FLAT 4 EFRAT L3 9045544
Business Address
Ben-Tzvi Avraham (Reporting) CIK: 0001944721 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25519382